Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Lamers-Karnebeek, Femke B.G.; Luime, Jolanda J.; Jansen, Tim L.; Van Riel, Piet L.C.M.; Jacobs, Johannes W.G.

doi:https://doi.org/10.1093/rheumatology/kez488

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

DSpace/Manakin Repository

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Lamers-Karnebeek, Femke B.G.; Luime, Jolanda J.; Jansen, Tim L.; Van Riel, Piet L.C.M.; Jacobs, Johannes W.G.

(2020) Rheumatology (United Kingdom), volume 59, issue 5, pp. 1170 - 1171

(Comment)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Rheumatology, Pharmacology (medical)

DOI: https://doi.org/10.1093/rheumatology/kez488

ISSN: 1462-0324

Publisher: Oxford University Press

(Peer reviewed)